The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 15, 2022
Filed:
Oct. 04, 2018
Applicant:
Glaxosmithkline Intellectual Property (No. 2) Limited, Brentford, GB;
Inventors:
Stephen John Atkinson, Stevenage, GB;
Emmanuel Hubert Demont, Stevenage, GB;
Lee Andrew Harrison, Stevenage, GB;
Simon Christopher Cranko Lucas, Stevenage, GB;
Alexander G. Preston, Stevenage, GB;
Jonathan Thomas Seal, Stevenage, GB;
Ian David Wall, Stevenage, GB;
Robert J. Watson, Stevenage, GB;
James Michael Woolven, Stevenage, GB;
Assignee:
GlaxoSmithKline Intellectual Property (No.2) Limited, Brentford, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4025 (2006.01); A61K 31/343 (2006.01); A61K 31/351 (2006.01); A61K 31/397 (2006.01); A61K 31/4155 (2006.01); A61K 31/4192 (2006.01); A61K 31/4196 (2006.01); A61K 31/443 (2006.01); A61K 31/4525 (2006.01); A61K 31/501 (2006.01); A61K 31/506 (2006.01); A61K 45/06 (2006.01); C07D 307/79 (2006.01); C07D 405/10 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 407/12 (2006.01); C07D 407/14 (2006.01); C07D 413/12 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4025 (2013.01); A61K 31/343 (2013.01); A61K 31/351 (2013.01); A61K 31/397 (2013.01); A61K 31/4155 (2013.01); A61K 31/4192 (2013.01); A61K 31/4196 (2013.01); A61K 31/443 (2013.01); A61K 31/4525 (2013.01); A61K 31/501 (2013.01); A61K 31/506 (2013.01); A61K 45/06 (2013.01); C07D 307/79 (2013.01); C07D 405/10 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 407/12 (2013.01); C07D 407/14 (2013.01); C07D 413/12 (2013.01); C07D 471/04 (2013.01);
Abstract
The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.